Home › Rectal Cancer › Minnesota › Minneapolis
Rectal Cancer clinical trials in Minneapolis, MN
4 studies for Rectal Cancer are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi away
Family Communications After Genetic Testing
RecruitingHealthy volunteers welcome
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi away
PRE-ISPY Phase I/II Oncology Platform Program
RecruitingPhase 1/2
- University of Minnesota Masonic Cancer Center, Minneapolis
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recruiting
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Minneapolis VA Medical Center, Minneapolis
- and 1 more
Rectal Cancer trials in other cities
- New York City, NY17 studies
- Boston, MA12 studies
- Houston, TX11 studies
- St. Louis, MO11 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Tampa, FL9 studies
- Seattle, WA9 studies
- Nashville, TN9 studies
- Rochester, MN8 studies
- Chicago, IL8 studies
- Aurora, CO8 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.